References
- Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, Butz ML, Thibodeau SN, Rabeneck L, Paszat LF, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012 Feb;142(2):248–256. https://doi.org/10.1053/j.gastro.2011.10.031
- Aitchison A, Pearson JF, Purcell RV, Frizelle FA, Keenan JI. Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia. PLoS One. 2022 Jun;17(6):e0269541. https://doi.org/10.1371/journal.pone.0269541
- Borozan I, Zaidi SH, Harrison TA, Phipps AI, Zheng J, Lee S, Trinh QM, Steinfelder RS, Adams J, Banbury BL, et al. Molecular and pathology features of colorectal tumors and patient outcomes are associated with Fusobacterium nucleatum and its subspecies animalis. Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):210–220. https://doi.org/10.1158/1055-9965.epi-21-0463
- Bosch LJ, Carvalho B, Fijneman RJ, Jimenez CR, Pinedo HM, van Engeland M, Meijer GA. Molecular tests for colorectal cancer screening. Clin Colorectal Cancer. 2011 Mar;10(1):8–23. https://doi.org/10.3816/ccc.2011.n.002
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. https://doi.org/10.3322/caac.21492
- Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, Varambally S. UAL-CAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017 Aug;19(8):649–658. https://doi.org/10.1016/j.neo.2017.05.002
- Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022 Mar;25:18–27. https://doi.org/10.1016/j.neo.2022.01.001
- Datorre JG, Dos Reis MB, de Carvalho AC, Porto J, Rodrigues GH, Lima AB, Reis MT, Hirai W, Hashimoto CL, Guimarães DP, et al. Enhancing colorectal cancer screening with droplet digital PCR analysis of Fusobacterium nucleatum in fecal immunochemical test samples. Cancer Prev Res (Phila). 2024 Oct;17(10):471–479. https://doi.org/10.1158/1940-6207.capr-23-0331
- Dohlman AB, Arguijo Mendoza D, Ding S, Gao M, Dressman H, Iliev ID, Lipkin SM, Shen X. The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe. 2021 Feb;29(2):281–298.e5. https://doi.org/10.1016/j.chom.2020.12.001
- Fardini Y, Wang X, Témoin S, Nithianantham S, Lee D, Shoham M, Han YW. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol. 2011 Dec;82(6):1468–1480. https://doi.org/10.1111/j.1365-2958.2011.07905.x
- Gao Y, Bi D, Xie R, Li M, Guo J, Liu H, Guo X, Fang J, Ding T, Zhu H, et al. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Signal Transduct Target Ther. 2021 Nov 19;6(1):398. https://doi.org/10.1038/s41392-021-00795-x
- Hua R, Yu J, Yan X, Ni Q, Zhi X, Li X, Jiang B, Zhu J. Syndecan-2 in colorectal cancer plays oncogenic role via epithelial-mesenchymal transition and MAPK pathway. Biomed Pharmacother. 2020 Jan;121:109630. https://doi.org/10.1016/j.biopha.2019.109630
- Huang S, Yang Z, Zou D, Dong D, Liu A, Liu W, Huang L. Rapid detection of nusG and fadA in Fusobacterium nucleatum by loop-mediated isothermal amplification. J Med Microbiol. 2016 Aug;65(8):760–769. https://doi.org/10.1099/jmm.0.000300
- Ikegami A, Chung P, Han YW. Complementation of the fadA mutation in Fusobacterium nucleatum demonstrates that the surface-exposed adhesin promotes cellular invasion and placental colonization. Infect Immun. 2009 Jul;77(7):3075–3079. https://doi.org/10.1128/iai.00209-09
- Irrazábal T, Belcheva A, Girardin SE, Martin A, Philpott DJ. The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell. 2014 Apr;54(2):309–320. https://doi.org/10.1016/j.mol-cel.2014.03.039
- Issa IA, Noureddine M. Colorectal cancer screening: An updated review of the available options. World J Gastroenterol. 2017 Jul;23(28):5086–5096. https://doi.org/10.3748/wjg.v23.i28.5086
- Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006 Apr;93(4):465–474. https://doi.org/10.1002/bjs.5278
- Li B, Liu S, Gao Y, Zheng L, Lu Y. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening. J Cancer Res Clin Oncol. 2023 Sep;149(12):10241–10253. https://doi.org/10.1007/s00432-023-04943-4
- Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, Jiang P, Shen H, Aster JC, Rodig S, Signoretti S, Liu JS, Liu XS. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016 Aug 22;17(1):174. https://doi.org/10.1186/s13059-016-1028-7
- Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017 Nov;77(21):e108–e110. https://doi.org/10.1158/0008-5472.CAN-17-0307
- Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016 Dec;65(12):1973–1980. https://doi.org/10.1136/gut-jnl-2015-310101
- Nguyen LH, Goel A, Chung DC. Pathways of colorectal carcinogenesis. Gastroenterology. 2020 Jan;158(2):291–302. https://doi.org/10.1053/j.gastro.2019.08.059
- Niu F, Wen J, Fu X, Li C, Zhao R, Wu S, Yu H, Liu X, Zhao X, Liu S, et al. Stool DNA test of methylated Syndecan-2 for the early detection of colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1411–1419. https://doi.org/10.1158/1055-9965.epi-17-0153
- Oberwalder M, Zitt M, Wöntner C, Fiegl H, Goebel G, Zitt M, Köhle O, Mühlmann G, Ofner D, Margreiter R, et al. SFRP2 methylation in fecal DNA – a marker for colorectal polyps. Int J Colorectal Dis. 2008 Jan;23(1):15–19. https://doi.org/10.1007/s00384-007-0355-2
- Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: Molecular approaches. Gastroenterology. 2005 Jan;128(1):192–206. https://doi.org/10.1053/j.gastro.2004.10.041
- Park H, Kim Y, Lim Y, Han I, Oh ES. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem. 2002 Aug 16;277(33):29730–29736. https://doi.org/10.1074/jbc.M202435200
- Pawa N, Arulampalam T, Norton JD. Screening for colorectal cancer: established and emerging modalities. Nat Rev Gastroenterol Hepatol. 2011 Nov 1;8(12):711–722. https://doi.org/10.1038/nrgastro.2011.205
- R Core Team. A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2022 [cited 2025 Jan 15]. Available from https://www.r-project.org
- Rabeneck L, Paszat LF, Hilsden RJ, Saskin R, Leddin D, Grunfeld E, Wai E, Goldwasser M, Sutradhar R, Stukel TA. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology. 2008 Dec;135(6):1899–1906.e1. https://doi.org/10.1053/j.gastro.2008.08.058
- Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013 Aug;14(2):195–206. https://doi.org/10.1016/j.chom.2013.07.012
- Ruf F, Schreck C, Wagner A, Grziwok S, Pagel C, Romero S, Kies-linger M, Shimono A, Peschel C, Götze KS, et al. Loss of Sfrp2 in the niche amplifies stress-induced cellular responses, and impairs the in vivo regeneration of the hematopoietic stem cell pool. Stem Cells. 2016 Sep;34(9):2381–2392. https://doi.org/10.1002/stem.2416
- Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut. 2015 Aug;64(8):1327–1337. https://doi.org/10.1136/gutjnl-2014-308074
- Vedeld HM, Goel A, Lind GE. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives. Semin Cancer Biol. 2018 Aug;51:36–49. https://doi.org/10.1016/j.semcancer.2017.12.004
- Wu Y, Jiao N, Zhu R, Zhang Y, Wu D, Wang AJ, Fang S, Tao L, Li Y, Cheng S, et al. Identification of microbial markers across populations in early detection of colorectal cancer. Nat Commun. 2021 May;12(1):3063. https://doi.org/10.1038/s41467-021-23265-y
- Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Watanabe H, Masuda K, Nishimoto Y, Kubo M, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019 Jun;25(6):968–976. https://doi.org/10.1038/s41591-019-0458-7
- Zhang Q, Yu K, Li S, Zhang X, Zhao Q, Zhao X, Liu Z, Cheng H, Liu ZX, Li X. gutMEGA: A database of the human gut MEtaGenome Atlas. Brief Bioinform. 2021 May;22(3):bbaa082. https://doi.org/10.1093/bib/bbaa082
- Zhao G, Liu X, Liu Y, Li H, Ma Y, Li S, Zhu Y, Miao J, Xiong S, Fei S, et al. Aberrant DNA methylation of SEPT9 and SDC2 in stool specimens as an integrated biomarker for colorectal cancer early detection. Front Genet. 2020 Jun;11:643. https://doi.org/10.3389/fgene.2020.00643
- Zhao G, Liu X, Liu Y, Ma Y, Yang J, Li H, Xiong S, Fei S, Zheng M, Zhao X. Methylated SFRP2 and SDC2 in stool specimens for colorectal cancer early detection: A cost-effective strategy for Chinese population. J Cancer. 2021 Mar;12(9):2665–2672. https://doi.org/10.7150/jca.52478